The Carlyle Group has acquired Tarrytown Expocare Pharmacy for an undisclosed amount, marking a significant corporate transaction in the specialized healthcare sector. This acquisition signifies a change in ownership for Tarrytown Expocare, a long-term care pharmacy dedicated to serving individuals within the intellectual and developmental disability (IDD) and behavioral health communities across more than 40 states.
Tarrytown Expocare Pharmacy is recognized for its focused approach to medication management and support. The company works directly with nurses and direct support professionals, providing expert pharmacy services, ongoing training, and essential resources designed to enhance efficiency, ensure medication accuracy, and deliver cost-effective solutions tailored to the unique needs of its specialized client base. Its mission centers on delivering high-quality, innovative, and compassionate pharmacy services for these communities nationwide.
This acquisition by The Carlyle Group reflects a strategic interest in the growing and specialized segment of long-term care pharmacy services. For Carlyle, the transaction represents an opportunity to invest in a company with a strong niche market position and a proven service model. Expected synergies include leveraging Carlyle's operational expertise and resources to potentially scale Tarrytown Expocare's operations, further optimize its service delivery, and expand its reach within the IDD and behavioral health sectors, thereby strengthening its market presence.
The new ownership aims to build upon Tarrytown Expocare's foundation as a dedicated pharmacy partner. Looking forward, the combined entity is poised to continue enhancing the quality and accessibility of specialized pharmacy services for individuals with intellectual and developmental disabilities and behavioral health needs. This strategic move is expected to support sustained growth and innovation within this critical healthcare segment.